Sanofi Pasteur unveils DTaP-IPV booster vaccine for preschoolers in India Ruchika Sharma2 Oct 2020 9:30 AM ISTNew Delhi: Sanofi Pasteur India, vaccine unit of pharma firm Sanofi, on Wednesday said it has launched a booster vaccine for preschoolers to protect...
Sanofi concludes acquisition of Principia Biopharma Ruchika Sharma29 Sept 2020 11:00 AM ISTParis: Drugmaker, Sanofi, recently announced that the company has successfully concluded the acquisition of Principia Biopharma Inc. for $100 per...
GSK, Sanofi ink Covid-19 vaccine supply deal with Canada Ruchika Sharma27 Sept 2020 9:15 AM ISTParis and London: Sanofi and GSK have recently announced that they have signed agreements with the Government of Canada for the supply of up to...
Sanofi not involved in COVID-19 human challenge trial: Spokesman Ruchika Sharma25 Sept 2020 9:15 AM ISTParis: Sanofi is not involved in the COVID-19 human challenge trials reported to be launched in Britain and its potential vaccines are not being used...
Sanofi halts trial of Covid-19 drug Kevzara after tests prove inconclusive Medical Dialogues Team21 Sept 2020 12:30 PM ISTPARIS: French pharma giant Sanofi said Tuesday that international Phase 3 clinical tests of its Kevzara drug for serious Covid-19 cases had...
Sanofi, Health2Sync ink pact for digital solution to diabetes management Ruchika Sharma20 Sept 2020 9:00 AM ISTTaipei: Health2Sync, a digital health startup, specializing in diabetes management, has entered into a partnership with Sanofi, a biopharmaceutical...
GSK, Sanofi to provide 300 million doses of COVID-19 vaccine to EU Ruchika Sharma19 Sept 2020 1:15 PM ISTA Phase 3 study is planned to begin by the end of 2020 and regulatory approval could be requested in the first half of 2021.
Sanofi Dupixent gets USFDA Breakthrough Therapy designation to treat eosinophilic esophagitis Ruchika Sharma16 Sept 2020 1:51 PM ISTParis: Drug major, Sanofi has recently secured Breakthrough Therapy designation from the U.S. Food and Drug Administration(USFDA) for its Dupixent (...
COVID-19: Pharma firms sign vaccine safety pledge MD Bureau9 Sept 2020 1:45 PM ISTThe CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi have signed the pledge.
Sanofi Plans Ingredients Unit IPO Within Months: Report Ruchika Sharma7 Sept 2020 9:00 AM ISTParis: Sanofi, the French pharmaceutical giant, plans to sell shares in its drug-ingredients division in the next few months, a senior executive...
Sanofi, GSK begin human trial of coronavirus vaccine candidate MD Bureau4 Sept 2020 10:00 AM ISTParis: Pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) on Thursday started a clinical trial for their jointly developed Covid-19 vaccine...
Sanofi COVID-19 drug Kevzara fails test, clinical trails halted Ruchika Sharma2 Sept 2020 5:12 PM ISTParis: In a major setback, French drugmaker Sanofi, recently announced that the company has halted the clinical trials of its COVID-19 drug Kevzara...
